IL1HY1: A novel interleukin-1 receptor antagonist gene - PubMed (original) (raw)

. 1999 Oct 5;263(3):702-6.

doi: 10.1006/bbrc.1999.1440.

Affiliations

• PMID: 10512743
• DOI: 10.1006/bbrc.1999.1440

IL1HY1: A novel interleukin-1 receptor antagonist gene

J J Mulero et al. Biochem Biophys Res Commun. 1999.

Abstract

Interleukin-1 is a potent mediator of inflammation, involved in regulating a wide variety of physiological and cellular events. We have identified and characterized a novel member of the human interleukin-1 gene family (IL1HY1). The encoded protein demonstrates significant amino acid homology to the receptor antagonist (IL-1ra) at 52%. The gene was mapped to the long arm of chromosome 2, in close proximity to the IL-1 locus. IL1HY1 message is tightly regulated being most predominantly expressed in the skin, but also detected in the spleen, brain leukocyte, and macrophage cell types. Furthermore, the message can be induced in THP-1 cells by phorbol ester (PMA) and lipopolysaccharide (LPS) treatment.

Copyright 1999 Academic Press.

PubMed Disclaimer

Similar articles

• Cloning of equine interleukin 1 receptor antagonist and determination of its full-length cDNA sequence.
  Howard RD, McIlwraith CW, Trotter GW, Nyborg JK. Howard RD, et al. Am J Vet Res. 1998 Jun;59(6):712-6. Am J Vet Res. 1998. PMID: 9622739
• Organization of the human interleukin-1 receptor antagonist gene IL1HY1.
  Mulero JJ, Nelken ST, Ford JE. Mulero JJ, et al. Immunogenetics. 2000 May;51(6):425-8. doi: 10.1007/s002510050640. Immunogenetics. 2000. PMID: 10866108
• Molecular cloning, expression and chromosomal localization of a novel human REG family gene, REG III.
  Nata K, Liu Y, Xu L, Ikeda T, Akiyama T, Noguchi N, Kawaguchi S, Yamauchi A, Takahashi I, Shervani NJ, Onogawa T, Takasawa S, Okamoto H. Nata K, et al. Gene. 2004 Sep 29;340(1):161-70. doi: 10.1016/j.gene.2004.06.010. Gene. 2004. PMID: 15556304
• Cloning, heterologous expression and characterization of murine interleukin 1 receptor antagonist protein.
  Shuck ME, Eessalu TE, Tracey DE, Bienkowski MJ. Shuck ME, et al. Eur J Immunol. 1991 Nov;21(11):2775-80. doi: 10.1002/eji.1830211119. Eur J Immunol. 1991. PMID: 1834470

Cited by

• The role of IL-38 in intestinal diseases - its potential as a therapeutic target.
  Wang Q, Ma L, An C, Wise SG, Bao S. Wang Q, et al. Front Immunol. 2022 Nov 3;13:1051787. doi: 10.3389/fimmu.2022.1051787. eCollection 2022. Front Immunol. 2022. PMID: 36405715 Free PMC article. Review.
• The Role of IL-37 and IL-38 in Colorectal Cancer.
  Dang J, He Z, Cui X, Fan J, Hambly DJ, Hambly BD, Li X, Bao S. Dang J, et al. Front Med (Lausanne). 2022 Feb 2;9:811025. doi: 10.3389/fmed.2022.811025. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35186997 Free PMC article. Review.
• IL-36 cytokines imprint a colitogenic phenotype on CD4+ T helper cells.
  Leon G, Hernandez Santana YE, Irwin N, Giannoudaki E, O'Neill S, Csizmadia I, Gogarty M, Lee TJ, Ruane D, Long A, Fallon PG, Hussey S, Walsh PT. Leon G, et al. Mucosal Immunol. 2022 Mar;15(3):491-503. doi: 10.1038/s41385-022-00488-w. Epub 2022 Feb 17. Mucosal Immunol. 2022. PMID: 35177818 Free PMC article.
• The Role of IL-37 and IL-38 in Obstetrics Abnormalities.
  Wang M. Wang M. Front Med (Lausanne). 2021 Aug 27;8:737084. doi: 10.3389/fmed.2021.737084. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34513891 Free PMC article. Review.
• The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?
  Wang X, Yi P, Liang Y. Wang X, et al. Front Immunol. 2021 May 13;12:662266. doi: 10.3389/fimmu.2021.662266. eCollection 2021. Front Immunol. 2021. PMID: 34054828 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)